{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T12:30:19Z","timestamp":1780489819423,"version":"3.54.1"},"reference-count":43,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,11,20]],"date-time":"2017-11-20T00:00:00Z","timestamp":1511136000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Province of Groningen","award":["T2002"],"award-info":[{"award-number":["T2002"]}]},{"name":"The Netherlands Institute for Regenerative Medicine"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Controlled Release"],"published-print":{"date-parts":[[2018,1]]},"DOI":"10.1016\/j.jconrel.2017.11.029","type":"journal-article","created":{"date-parts":[[2017,11,22]],"date-time":"2017-11-22T05:02:03Z","timestamp":1511326923000},"page":"258-265","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":27,"special_numbering":"C","title":["Pharmacokinetics of a sustained release formulation of PDGF\u03b2-receptor directed carrier proteins to target the fibrotic liver"],"prefix":"10.1016","volume":"269","author":[{"given":"F.","family":"van Dijk","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.","family":"Teekamp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Beljaars","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Post","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Zuidema","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Steendam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y.O.","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.W.","family":"Frijlink","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Schuppan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"Poelstra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W.L.J.","family":"Hinrichs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Olinga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jconrel.2017.11.029_bb0005","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.jconrel.2014.03.053","article-title":"An overview of clinical and commercial impact of drug delivery systems","volume":"190","author":"Anselmo","year":"2014","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2017.11.029_bb0010","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1021\/jacs.5b09974","article-title":"Emerging frontiers in drug delivery","volume":"138","author":"Tibbitt","year":"2016","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.jconrel.2017.11.029_bb0015","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1007\/BF03190201","article-title":"Pharmacokinetic characterization of controlled-release formulations","volume":"15","author":"Steinijans","year":"1990","journal-title":"Eur. J. Drug Metab. Pharmacokinet."},{"key":"10.1016\/j.jconrel.2017.11.029_bb0020","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.jconrel.2004.10.015","article-title":"Microencapsulation by solvent extraction\/evaporation: reviewing the state of the art of microsphere preparation process technology","volume":"102","author":"Freitas","year":"2005","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2017.11.029_bb0025","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1517\/17425247.2015.961420","article-title":"Long-term delivery of protein therapeutics","volume":"12","author":"Vaishya","year":"2015","journal-title":"Expert Opin. Drug Deliv."},{"key":"10.1016\/j.jconrel.2017.11.029_bb0030","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1177\/1756283X11413002","article-title":"Current status of novel antifibrotic therapies in patients with chronic liver disease","volume":"4","author":"Cohen-Naftaly","year":"2011","journal-title":"Therap. Adv. Gastroenterol."},{"key":"10.1016\/j.jconrel.2017.11.029_bb0035","doi-asserted-by":"crossref","first-page":"s38","DOI":"10.1016\/S0168-8278(02)00429-4","article-title":"Liver fibrosis - from bench to bedside","volume":"38","author":"Friedman","year":"2003","journal-title":"J. Hepatol."},{"key":"10.1016\/j.jconrel.2017.11.029_bb0040","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1016\/S0140-6736(08)60383-9","article-title":"Liver cirrhosis","volume":"371","author":"Schuppan","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/j.jconrel.2017.11.029_bb0045","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1055\/s-0035-1550055","article-title":"Antifibrotic therapies in the liver","volume":"35","author":"Mehal","year":"2015","journal-title":"Semin. Liver Dis."},{"key":"10.1016\/j.jconrel.2017.11.029_bb0050","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1097\/MOG.0b013e3282f8e27e","article-title":"Liver transplantation: an update 2008","volume":"24","author":"Said","year":"2008","journal-title":"Curr. Opin. Gastroenterol."},{"key":"10.1016\/j.jconrel.2017.11.029_bb0055","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1002\/hep.23123","article-title":"Targeting liver fibrosis: strategies for development and validation of antifibrotic therapies","volume":"50","author":"Popov","year":"2009","journal-title":"Hepatology"},{"key":"10.1016\/j.jconrel.2017.11.029_bb0060","doi-asserted-by":"crossref","first-page":"1887","DOI":"10.1172\/JCI66028","article-title":"Evolving therapies for liver fibrosis","volume":"123","author":"Schuppan","year":"2013","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.jconrel.2017.11.029_bb0065","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1007\/s40259-015-0133-6","article-title":"Fusion proteins for half-life extension of biologics as a strategy to make biobetters","volume":"29","author":"Strohl","year":"2015","journal-title":"BioDrugs"},{"key":"10.1016\/j.jconrel.2017.11.029_bb0070","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1038\/nbt.3040","article-title":"Biopharmaceutical benchmarks 2014","volume":"32","author":"Walsh","year":"2014","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.jconrel.2017.11.029_bb0075","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1002\/hep.24395","article-title":"Novel engineered targeted interferon-gamma blocks hepatic fibrogenesis in mice","volume":"54","author":"Bansal","year":"2011","journal-title":"Hepatology"},{"key":"10.1016\/j.jconrel.2017.11.029_bb0080","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1038\/labinvest.2008.71","article-title":"Platelet-derived growth factor isoform expression in carbon tetrachloride-induced chronic liver injury","volume":"88","author":"Borkham-Kamphorst","year":"2008","journal-title":"Lab. Investig."},{"key":"10.1016\/j.jconrel.2017.11.029_bb0085","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1172\/JCI117497","article-title":"Induction of beta-platelet-derived growth factor receptor in rat hepatic lipocytes during cellular activation in vivo and in culture","volume":"94","author":"Wong","year":"1994","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.jconrel.2017.11.029_bb0090","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1016\/S0006-2952(03)00445-3","article-title":"The preferential homing of a platelet derived growth factor receptor-recognizing macromolecule to fibroblast-like cells in fibrotic tissue","volume":"66","author":"Beljaars","year":"2003","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.jconrel.2017.11.029_bb0095","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1517\/17425247.2012.709844","article-title":"Recent advances in polymeric microspheres for parenteral drug delivery\u2014part 1","volume":"9","author":"Mao","year":"2012","journal-title":"Expert Opin. Drug Deliv."},{"key":"10.1016\/j.jconrel.2017.11.029_bb0100","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.ejpb.2014.02.012","article-title":"Tailored protein release from biodegradable poly(\u03b5-caprolactone-PEG)-b-poly(\u03b5-caprolactone) multiblock-copolymer implants","volume":"87","author":"Stankovi\u0107","year":"2014","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.jconrel.2017.11.029_bb0105","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.ijpharm.2015.01.007","article-title":"Protein release from water-swellable poly(d,l-lactide-PEG)-b-poly(\u03f5-caprolactone) implants","volume":"480","author":"Stankovi\u0107","year":"2015","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2017.11.029_bb0110","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.ijpharm.2017.09.072","article-title":"Polymeric microspheres for the sustained release of a protein-based drug carrier targeting the PDGF\u03b2 -receptor in the fibrotic kidney","volume":"534","author":"Teekamp","year":"2017","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2017.11.029_bb0115","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1016\/j.ejps.2013.05.011","article-title":"Low temperature extruded implants based on novel hydrophilic multiblock copolymer for long-term protein delivery","volume":"49","author":"Stankovi\u0107","year":"2013","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.jconrel.2017.11.029_bb0120","doi-asserted-by":"crossref","first-page":"12743","DOI":"10.1074\/jbc.275.17.12743","article-title":"Successful targeting to rat hepatic stellate cells using albumin modified with cyclic peptides that recognize the collagen type VI receptor","volume":"275","author":"Beljaars","year":"2000","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jconrel.2017.11.029_bb0125","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1016\/j.jhep.2005.06.025","article-title":"Mdr2 (Abcb4)\u2212\/\u2212 mice spontaneously develop severe biliary fibrosis via massive dysregulation of pro- and antifibrogenic genes","volume":"43","author":"Popov","year":"2005","journal-title":"J. Hepatol."},{"key":"10.1016\/j.jconrel.2017.11.029_bb0130","series-title":"MULTIFIT: An Interactive Program for Nin-Linear Curve-fitting of Several Pharmacokinetic Models and Mathematical Functions","author":"Proost","year":"1992"},{"key":"10.1016\/j.jconrel.2017.11.029_bb0135","series-title":"Medicines in Development: Biologics","author":"PhRMA","year":"2013"},{"key":"10.1016\/j.jconrel.2017.11.029_bb0140","first-page":"781","article-title":"In vitro in vivo correlation basis and application to slow release injectable formulation","volume":"63","author":"Cardot","year":"2015","journal-title":"Farmacia."},{"key":"10.1016\/j.jconrel.2017.11.029_bb0145","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1016\/j.jconrel.2014.04.048","article-title":"Controlled release for local delivery of drugs: barriers and models","volume":"190","author":"Weiser","year":"2014","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2017.11.029_bb0150","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.jconrel.2014.03.011","article-title":"Improving the outcomes of biopharmaceutical delivery via the subcutaneous route by understanding the chemical, physical and physiological properties of the subcutaneous injection site","volume":"182","author":"Kinnunen","year":"2014","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2017.11.029_bb0155","doi-asserted-by":"crossref","first-page":"727","DOI":"10.4155\/tde.11.31","article-title":"Electrostatic interactions of monoclonal antibodies with subcutaneous tissue","volume":"2","author":"Mach","year":"2011","journal-title":"Ther. Deliv."},{"key":"10.1016\/j.jconrel.2017.11.029_bb0160","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/0014-4827(91)90351-T","article-title":"Insulin binds to type V collagen with retention of mitogenic activity","volume":"194","author":"Yaoi","year":"1991","journal-title":"Exp. Cell Res."},{"key":"10.1016\/j.jconrel.2017.11.029_bb0165","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/0006-3002(63)91646-9","article-title":"On the interaction between polysaccharides and other macromolecules III. The use of hyaluronic acid for the separation of macromolecules in the ultracentrifuge","volume":"78","author":"Laurent","year":"1963","journal-title":"Biochim. Biohys. Acta"},{"key":"10.1016\/j.jconrel.2017.11.029_bb0170","doi-asserted-by":"crossref","first-page":"5882","DOI":"10.1039\/c3ra00063j","article-title":"Interplay of ion specificity, pH and buffers: insights from electrophoretic mobility and pH measurements of lysozyme solutions","volume":"3","author":"Cugia","year":"2013","journal-title":"RSC Adv."},{"key":"10.1016\/j.jconrel.2017.11.029_bb0175","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1208\/s12248-012-9367-0","article-title":"Mechanistic determinants of biotherapeutics absorption following SC Administration","volume":"14","author":"Richter","year":"2012","journal-title":"AAPS J."},{"key":"10.1016\/j.jconrel.2017.11.029_bb0180","doi-asserted-by":"crossref","first-page":"2422","DOI":"10.1016\/S0006-3495(01)76211-X","article-title":"The conformation of serum albumin in solution: a combined phosphorescence depolarization-hydrodynamic modeling study","volume":"80","author":"Ferrer","year":"2001","journal-title":"Biophys. J."},{"key":"10.1016\/j.jconrel.2017.11.029_bb0185","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1038\/ki.1990.332","article-title":"Pathophysiological aspects of edema formation in diabetic nephropathy","volume":"38","author":"Hommel","year":"1990","journal-title":"Kidney Int."},{"key":"10.1016\/j.jconrel.2017.11.029_bb0190","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S0169-409X(01)00153-3","article-title":"Lymphatic transport of proteins after s.c. injection: implications of animal model selection","volume":"50","author":"Porter","year":"2001","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2017.11.029_bb0195","doi-asserted-by":"crossref","first-page":"1744","DOI":"10.1002\/jps.23058","article-title":"Noninvasive real-time fluorescence imaging of the lymphatic uptake of BSA\u2013IRDye 680 conjugate administered subcutaneously in mice","volume":"101","author":"Wu","year":"2012","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.jconrel.2017.11.029_bb0200","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.jconrel.2015.07.016","article-title":"A novel in vitro method to model the fate of subcutaneously administered biopharmaceuticals and associated formulation components","volume":"214","author":"Kinnunen","year":"2015","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2017.11.029_bb0205","doi-asserted-by":"crossref","first-page":"2419","DOI":"10.1158\/1535-7163.MCT-11-0758","article-title":"Selective targeting of interferon \u03b3 to stromal fibroblasts and pericytes as a novel therapeutic approach to inhibit angiogenesis and tumor growth","volume":"11","author":"Bansal","year":"2012","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.jconrel.2017.11.029_bb0210","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.jconrel.2010.03.018","article-title":"A novel approach to deliver anticancer drugs to key cell types in tumors using a PDGF receptor-binding cyclic peptide containing carrier","volume":"145","author":"Prakash","year":"2010","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2017.11.029_bb0215","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1186\/1710-1492-7-S1-S1","article-title":"An introduction to immunology and immunopathology","volume":"7","author":"Warrington","year":"2011","journal-title":"Allergy, Asthma Clin. Immunol."}],"container-title":["Journal of Controlled Release"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365917310258?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365917310258?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,25]],"date-time":"2018-09-25T08:38:22Z","timestamp":1537864702000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168365917310258"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,1]]},"references-count":43,"alternative-id":["S0168365917310258"],"URL":"https:\/\/doi.org\/10.1016\/j.jconrel.2017.11.029","relation":{},"ISSN":["0168-3659"],"issn-type":[{"value":"0168-3659","type":"print"}],"subject":[],"published":{"date-parts":[[2018,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pharmacokinetics of a sustained release formulation of PDGF\u03b2-receptor directed carrier proteins to target the fibrotic liver","name":"articletitle","label":"Article Title"},{"value":"Journal of Controlled Release","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jconrel.2017.11.029","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}